No current technology can comprehensively measure bone quality, so clinicians must be attuned to the various tools available to gauge each component — bone density, accumulated microscopic damage, bone turnover, and the quality of collagen or mineral crystal size — individually. In his Monday lecture,…
Hanna Kim, MD, MS, and Stacy Ardoin, MD, MSc, reviewed significant contributions to the literature in pediatric rheumatology made in the past year, including new data on mental health in young patients living with rheumatic disease. Investigators have found that the risk of psychiatric disorders…
In the second of three plenary sessions, experts including Bryant England, MD, PhD, addressed emerging research on the effects of sodium-glucose cotransporter 2 inhibition in lupus; T cell differentiation in lupus; the protective effects of gut microbiome transplantation; TNF inhibition in rheumatoid arthritis and interstitial…
Puja Mehta, MD, MBBS, offered reasoning and practical steps to recognize testimonial injustice, create inclusive cultures, and develop potential actions for eliminating bias, both as individuals and as organizations.
Experts including Alvin F. Wells, MD, PhD, FACR, FACP, discussed health disparities, drivers of those disparities, and creative ways to overcome them to create better outcomes for patients with rheumatic disease.
These two sessions, one featuring adult cases and one featuring pediatric cases, invite audience members to share how they would approach the clinical mysteries being presented. At the end, they will find out whether they made the correct diagnosis.
Two rheumatologists who have been through the process, Tien-I Karleen Su, MD, and Crystal Withers, MD, PhD, will go through a checklist of the myriad aspects that must be taken into account to open a private practice and sustain the new business.
The drug sotatercept targets a novel pathway that is not targeted with any of the current medications for PAH. Lewis Rubin, MD, will describe the mechanism of action of this drug and how it differs from previous PAH treatment.